Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients
Mar 24, 2020 | FeaturedInfectious DiseasesResearch |
The Mount Sinai Health System this week plans to initiate a procedure known as plasmapheresis, where the antibodies from patients who have recovered from COVID-19 will be transferred into critically ill patients with the disease, with the expectation that the antibodies will neutralize it.
The process of using antibody-rich plasma from COVID-19 patients to help others was used successfully in China, according to a state-owned organization, which reported that some patients improved within 24 hours, with reduced inflammation and viral loads, and better oxygen levels in the blood.
Read more: https://inside.mountsinai.org/blog/mount-sinai-to-begin-the-transfer-of-covid-19-antibodies-into-critically-ill-patients/?fbclid=IwAR06MRKSUuQw-WSvHGLsVJtqgHEOJa8Kw9kY9uGcEU5yK56zw95BI_KeKag#.XnvuzfkUx5J.facebook

Your comment will be posted after it is approved.


Leave a Reply.